Scaffold Therapeutics
About Scaffold Therapeutics
Scaffold Therapeutics develops RNA-targeted cancer therapies using machine learning to analyze and regulate RNA modifications that affect stability, transcription, and degradation. Their platform accelerates drug discovery across oncology and neurodegenerative diseases by providing insights into pathway biology and aligning experimental research with clinical objectives.
```xml <problem> Traditional drug discovery processes for cancer and neurodegenerative diseases are slow and inefficient, often failing to fully leverage the complexities of RNA biology. Understanding and manipulating RNA modifications, which influence stability, transcription, and degradation, remains a significant challenge in developing effective therapies. </problem> <solution> Scaffold Therapeutics has developed a drug discovery platform that uses machine learning to analyze and regulate RNA modifications, enabling the development of RNA-targeted therapies for oncology and neurodegenerative diseases. The platform provides insights into pathway biology and aligns experimental research with clinical objectives, accelerating the identification of promising drug candidates. By focusing on RNA modifications that control stability, transcription, and degradation, Scaffold Therapeutics aims to create a pipeline of assets targeting clinically validated and first-in-class biology. The platform helps to overcome the limitations of traditional methods by providing a more comprehensive understanding of the transcriptome. </solution> <features> - Machine learning-driven analysis of RNA modifications - Identification of novel drug targets in oncology and neurodegenerative diseases - Regulation of RNA stability, transcription, and degradation - Platform designed to accelerate drug discovery - Focus on clinically validated and first-in-class biology </features> <target_audience> The primary target audience includes pharmaceutical companies and research institutions focused on developing novel therapies for cancer and neurodegenerative diseases. </target_audience> ```
What does Scaffold Therapeutics do?
Scaffold Therapeutics develops RNA-targeted cancer therapies using machine learning to analyze and regulate RNA modifications that affect stability, transcription, and degradation. Their platform accelerates drug discovery across oncology and neurodegenerative diseases by providing insights into pathway biology and aligning experimental research with clinical objectives.
Where is Scaffold Therapeutics located?
Scaffold Therapeutics is based in Boston, United States.
When was Scaffold Therapeutics founded?
Scaffold Therapeutics was founded in 2022.
How much funding has Scaffold Therapeutics raised?
Scaffold Therapeutics has raised 2150000.
- Location
- Boston, United States
- Founded
- 2022
- Funding
- 2150000
- Employees
- 3 employees